Elevated cardiac troponin T in cirrhotic patients with emergency care admissions: Associations with mortality

Mayada Elnegouly1,2, Katrin Umgelter3, Wajima Safi4

  • 12nd Medical Department, Technical University of Munich, Munich, Germany.

Insights

Elevated cardiac troponin T (cTnT) levels in emergency department patients with cirrhosis, even without heart disease, predict higher 1-year mortality. This finding aids in risk stratification for cirrhotic patients admitted to the ED.

Area of Science:

  • Cardiology
  • Hepatology
  • Emergency Medicine

Background:

  • High mortality rates in cirrhotic patients admitted to the emergency department (ED).
  • Prognostic factors are crucial for prioritizing care in this population.
  • Need to identify novel biomarkers for risk stratification in liver cirrhosis.

Purpose of the Study:

  • To assess the association between cardiac troponin T (cTnT) levels and 1-year mortality.
  • To evaluate cTnT as a prognostic factor in cirrhotic patients without known cardiac disease admitted to the ED.

Main Methods:

  • Retrospective analysis of 237 cirrhotic ED patients from October 2009 to August 2015.
  • Initial cTnT levels measured with the first lab panel.
  • 365-day mortality follow-up, adjusting for Model for End-stage Liver Disease (MELD) and CLIF-C-ACLF scores.

Main Results:

  • 49% of patients had elevated cTnT levels (>14 ng/L).
  • Elevated cTnT and higher CLIF-C-ACLF scores were independently associated with increased 1-year mortality.
  • Hazard ratio for cTnT: 1.014 per ng/L increase (P=0.008).

Conclusions:

  • A significant proportion of cirrhotic ED patients exhibit elevated cTnT without cardiac disease.
  • Elevated cTnT is a significant independent predictor of 1-year mortality in this cohort.
  • cTnT may serve as a valuable prognostic marker in emergency settings for liver cirrhosis patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
979
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
325
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
450
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
507